ZNTL

Zentalis Pharmaceuticals Inc.

Price

$3.82

return (12m)

140.25%

p/e

-1.81

p/bv

1.76

DIVIDEND YIELD

0.00%

ZNTL price

Zentalis Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ZNTL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-27.51%

3 months

-7.73%

1 year

140.25%

2 years

13.69%

5 years

-93.09%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ZNTL

Valuation

P/E

-1.81

Sector -4.38

Industry -4.38

P/BV

1.76

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-1.77

Sector -263.09

Industry -263.09

EV/EBIT

-1.77

Sector -702.90

Industry -702.90

P/EBITDA

-1.66

Sector -4.39

Industry -4.39

P/EBIT

-1.65

Sector -4.73

Industry -4.73

P/Total Assets

1.18

Sector 1.49

Industry 1.49

P/Net Current Assets

2.31

Sector -11.70

Industry -11.70

P/Working Capital

1.76

Sector -3.19

Industry -3.19

EPS

-1.97

Sector -2.14

Industry -2.14

BVPS

2.02

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-97.15%

Sector -65.14%

Industry -65.14%

ROA

-64.81%

Sector -65.53%

Industry -65.53%

ROIC

-514.52%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.82

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.95

Sector -6.07

Industry -6.07

Net Debt / EBIT

3.93

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.22

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.67

Sector 0.41

Industry 0.41

Liabilities/Assets

0.33

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-2.54%

Sector -

Industry -

Fundamentals ZNTL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ZNTL Zentalis Pharmaceuticals Inc.	$3.82	132.93%	0.00%	-1.81	1.76	-97.15%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ZNTL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Zentalis Pharmaceuticals

Zentalis Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

124

Employees

Zentalis Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $253.12 million, with shareholders equity totaling $143.65 million.

The company employs approximately 124 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Zentalis Pharmaceuticals Inc. reported $- in revenue, generating net income of $-139.55 million.

Key financial metrics include a P/E ratio of -1.81, a price-to-book (P/B) ratio of 1.76, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ZNTL.

Market cap

$253.12 million

Net worth

$143.65 million

$143,650,000.00

Assets

$215.33 million

$215,330,000.00

Total Shares Outstanding

71.00 million

71,000,000

Average Daily Trading Volume

$1.25 million

$1,252,186.00

Sector

Health Care

Industry

Biotechnology

ZNTL

ZNTL revenue and profits

Financial Results ZNTL

DRAG THE FRAME TO SEE MORE DATA

ZNTL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Zentalis Pharmaceuticals (ZNTL) today?

A cotação de Zentalis Pharmaceuticals (ZNTL) hoje está em US$ 3.82, com uma variação de 140.25% em relação ao último ano. A cotação de Zentalis Pharmaceuticals (ZNTL) iniciou o ano negociando na casa dos US$ 1.35 e hoje está em US$ 3.82. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Zentalis Pharmaceuticals (ZNTL) e dados de ações do Ibovespa e mercados internacionais.

Quando Zentalis Pharmaceuticals (ZNTL) paga dividendos?

Zentalis Pharmaceuticals (ZNTL) não distribuiu dividendos no último ano.

Is Zentalis Pharmaceuticals (ZNTL) a good investment?

Atualmente, Zentalis Pharmaceuticals (ZNTL) está cotada a US$ 3.82, com um P/L de -1.81, representando um desvio de -257% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 140.25 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 140.25%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Zentalis Pharmaceuticals (ZNTL) stock?

Investir em ações de Zentalis Pharmaceuticals (ZNTL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Zentalis Pharmaceuticals (ZNTL) yield today?

A rentabilidade de Zentalis Pharmaceuticals (ZNTL) foi de -27.51% no último mês, 140.25% no último ano e -93.09% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Zentalis Pharmaceuticals (ZNTL) hoje, o investimento total seria de US$ 382.00, com base na cotação atual de US$ 3.82.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 917.76
Em 5 anos: US$ 26.40
Em 10 anos: US$ 382.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ZNTL

Zentalis Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ZNTL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ZNTL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Zentalis Pharmaceuticals

Zentalis Pharmaceuticals Inc.

United States

12 years

2020

124

PROFIT X PRICE ZNTL

Financial Results ZNTL

ZNTL cash flow

Asset, Revenue and Profit Growth - ZNTL

ZNTL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions